Fundraising Fox

Peptinovo

Ann Arbor, US · 2 known investors

peptinovo.com ↗

Peptinovo develops a patented drug delivery platform (PALM carrier technology) intended to improve the efficacy of approved chemotherapies for a range of solid tumors while reducing serious side effects. Its lead candidate, PNB-281, pairs its carrier with paclitaxel, with additional chemotherapy drug candidates in development.

BiotechHealthtech

Founders & leadership

RH
REYNOLD HOMANExecutive Officer, Director
BE
BILL ELLIOTTExecutive Officer
ST
STEVE TOKAZExecutive Officer, Director
DR
DAVID ROMENESCODirector
FB
FRED BROWNDirector

Investors · 2

ID VenturesDetroit · $50K – $250K
WMU Biosciences Research & Commercialization CenterKalamazoo · $100K – $250K

Reported raises · per SEC filings

Form D private placements
▶$1.3MraisedDec 2024 · 12 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • DAVID ROMENESCODirector
  • FRED BROWNDirector
  • REYNOLD HOMANExecutive Officer, Director
  • BILL ELLIOTTExecutive Officer
  • STEVE TOKAZExecutive Officer, Director
Offering amount
$10M
Amount sold
$1.3M
First sale
Sep 2024
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$955KraisedJun 2021 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • STEVE TOKAZDirector
  • REYNOLD HOMANExecutive Officer, Director
Amount sold
$955K
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.